GJA8-associated developmental eye disorders: a new multicentre study highlights mutational hotspots and genotype-phenotype correlations
- PMID: 40301690
- PMCID: PMC12229616
- DOI: 10.1038/s41431-025-01843-8
GJA8-associated developmental eye disorders: a new multicentre study highlights mutational hotspots and genotype-phenotype correlations
Abstract
Variants in gap junction protein alpha 8 (GJA8), the gene encoding connexin 50 (Cx50), are primarily associated with developmental cataract, although some are associated with severe structural eye anomalies, such as aphakia (absent lens), microphthalmia (small eyes), and sclerocornea. To further define the relationship of GJA8 variants to ocular developmental disorders, we screened four large international cohorts with structural eye anomalies, including anophthalmia, microphthalmia, and coloboma (AMC) or cataracts. We identified 15 new families carrying 14 different heterozygous GJA8 variants (12 missense variants and two 1q21 microdeletions). The missense variants comprised 10 previously reported alterations in cases with eye anomalies [p.(Gly22Ser), p.(Val44Met), p.(Asp67Gly), p.(Arg76Cys), p.(Pro88Leu), p.(Gly94Glu), p.(Gly94Arg), p.(His98Arg), p.(Pro189Ser), and p.(Arg198Trp)] and two not yet linked with disease [p.(Thr39Met) and p.(Tyr66Asp)]. Their associated phenotypes ranged from isolated cataracts to a combination of microphthalmia and cataract with/without sclerocornea. Our study confirms GJA8 variants as an important source of genetic diagnoses for families with structural eye anomalies in addition to cataract and highlights specific mutational hotspots. Furthermore, we confirm an important genotype-phenotype correlation between sclerocornea and the p.(Gly94Arg) variant, and detail intra- and inter-familial phenotypic variability, which is important for clinical assessment and genetic counselling.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethical approval: Families 7 and 8 are from the ‘Genetics of Eye and Brain anomalies’ research study UK [Cambridge East Ethics Committee (04/Q0104/129)]. Families 2, 4, 14 and 15 are from the ‘Genetics of Congenital Ocular Disorders’ study, Fundación Jimenez Díaz University Hospital Spain [Ethics Research Committee FJD (PIC015-18)]. Families 3, 5, 6, 9, 10 and 13 are from the ‘Genetic Studies of Human Ocular Disorders’ study USA [Institutional Review Board of the Medical College of Wisconsin (PRO45954), Children’s Wisconsin (124172) and Einstein Healthcare Network (HN2191)]. Families 1, 11 and 12 were identified through diagnostic testing in France. Consent was obtained from all participants according to the tenets of the Declaration of Helsinki.
Figures
References
-
- Shah SP, Taylor AE, Sowden JC, Ragge NK, Russell-Eggitt I, Rahi JS, et al. Anophthalmos, microphthalmos, and typical coloboma in the United Kingdom: a prospective study of incidence and risk. Invest Ophthalmol Vis Sci. 2011;52:558–64. - PubMed
-
- Hornby SJ, Gilbert CE, Rahi JK, Sil AK, Xiao Y, Dandona L, et al. Regional variation in blindness in children due to microphthalmos, anophthalmos and coloboma. Ophthalmic Epidemiol. 2000;7:127–38. - PubMed
-
- de Verdier K, Ulla E, Löfgren S, Fernell E. Children with blindness - major causes, developmental outcomes and implications for habilitation and educational support: a two-decade, Swedish population-based study. Acta Ophthalmol. 2018;96:295–300. - PubMed
-
- Plaisancié J, Ceroni F, Holt R, Zazo Seco C, Calvas P, Chassaing N, et al. Genetics of anophthalmia and microphthalmia. Part 1: Non-syndromic anophthalmia/microphthalmia. Hum Genet. 2019;138:799–830. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
